Work

A Novel Inhibitor that Targets both p53‐Dependent Apoptotic and Autophagy Pathways as a Pancreatic Cancer Therapeutic

Year: 2018

Type: article

Source: The FASEB Journal

DOI: 10.1096/fasebj.2018.32.1_supplement.836.16

Authors: Jiongjia Cheng, Dong‐Hoon Lee, Karl J. Okolotowicz, Andrew M. Lowy, John R. Cashman

Institutions: ChemRegen (United States), Human BioMolecular Research Institute, University of California San Diego

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: Novel Small Molecule Therapeutics for Pancreatic Cancer, RON Receptor in Pancreatic Cancer Biology and Therapy

OpenAlex ID: W3177490331

FWCI:

Cites:

Cited by:

Related to: 10